MEDP
Medpace Holdings Inc
NASDAQ: MEDP · HEALTHCARE · DIAGNOSTICS & RESEARCH
$413.59
+0.96% today
Updated 2026-04-29
Market cap
$11.81B
P/E ratio
26.04
P/S ratio
4.41x
EPS (TTM)
$15.88
Dividend yield
—
52W range
$284 – $629
Volume
0.4M
Medpace Holdings Inc (MEDP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
17.20%
Operating margin
20.00%
ROE
77.20%
ROA
17.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | $272.89M | $24.84M | 45.62% | 21.57% | 9.10% |
| 2014 | $290.04M | $-15.57M | 46.11% | 8.96% | -5.37% |
| 2015 | $359.06M | $-8.67M | 43.56% | 5.73% | -2.42% |
| 2016 | $421.58M | $13.43M | 40.83% | 12.45% | 3.18% |
| 2017 | $436.15M | $39.12M | 40.05% | 14.87% | 8.97% |
| 2018 | $704.59M | $73.19M | 30.59% | 14.34% | 10.39% |
| 2019 | $860.97M | $100.44M | 28.54% | 14.78% | 11.67% |
| 2020 | $925.92M | $145.38M | 30.10% | 18.04% | 15.70% |
| 2021 | $1.14B | $181.85M | 28.73% | 17.39% | 15.92% |
| 2022 | $1.46B | $245.37M | 29.62% | 19.09% | 16.81% |
| 2023 | $1.89B | $282.81M | 27.81% | 17.86% | 15.00% |
| 2024 | $2.11B | $404.39M | 31.12% | 21.19% | 19.17% |
| 2025 | $2.53B | $451.12M | 30.06% | 21.14% | 17.83% |